Sergio Romagnani

发表

Review article Supported by a grant from Astra Zeneca Pharmaceuticals

Sergio Romagnani, S. Romagnani, 2000 .

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

Sergio Romagnani, Enrico Maggi, Annalisa Pasini, 2006, Stem cells.

Do studies in humans better depict Th17 cells?

Sergio Romagnani, F. Annunziato, S. Romagnani, 2009, Blood.

The COVID-19 infection: lessons from the Italian experience

Guido Gnone, Sergio Romagnani, Francesco Guzzi, 2020, Journal of public health policy.

Human Th17 cells: Are they different from murine Th17 cells?

Sergio Romagnani, Enrico Maggi, L. Cosmi, 2009, European journal of immunology.

The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

Sergio Romagnani, S. Romagnani, 2004, Immunology.

Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells

Sergio Romagnani, Enrico Maggi, Annalisa Pasini, 2006 .

An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4

Sergio Romagnani, Claudio Orlando, Enrico Maggi, 2003, The Journal of experimental medicine.

Immunologic influences on allergy and the TH1/TH2 balance.

Sergio Romagnani, S. Romagnani, 2004, The Journal of allergy and clinical immunology.

CXC chemokines: the regulatory link between inflammation and angiogenesis.

Sergio Romagnani, M. Serio, F. Annunziato, 2004, Trends in immunology.

Macrophage-Derived Chemokine and EBI1-Ligand Chemokine Attract Human Thymocytes in Different Stage of Development and Are Produced by Distinct Subsets of Medullary Epithelial Cells: Possible Implications for Negative Selection1

Sergio Romagnani, Roberto Manetti, Enrico Maggi, 2000, The Journal of Immunology.